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Abstract   The study of transcriptional regulation often needs the integration of 
diverse yet independent data. In the present work, sequence conservation, predic-
tion of transcription factor binding sites (TFBS) and gene expression analysis have 
been applied to the detection of putative transcription factor (TF) modules in the 
regulatory region of the FGFR3 oncogene. Several TFs with conserved binding 
sites in the FGFR3 regulatory region have shown high positive or negative corre-
lation with FGFR3 expression both in urothelial carcinoma and in benign nevi. By 
means of conserved TF cluster analysis, two different TF modules have been iden-
tified in the promoter and first intron of FGFR3 gene. These modules contain acti-
vating AP2, E2F, E47 and SP1 binding sites plus motifs for EGR with possible 
repressor function. 
Keywords: FGFR3, Bladder Cancer, Transcription Factors, Binding Sites, Con-
served Sequence, Gene Expression Regulation. 
Introduction 
Fibroblast growth factor receptor 3 (FGFR3) is frequently activated by mutation 
and/or over-expressed in urothelial carcinoma (UC) and benign nevi of the skin 
(BN), triggering the MAPK pathway and leading or contributing to cell growth 
and tumorigenesis. 
Although some transcription factors like SP1, AP2δ and E47 are known to pro-
mote FGFR3 transcription by binding to specific sites  in the promoter and first in-
tron [1-3], the regulatory mechanism is not yet fully understood. The discovery of 
additional TFs involved in FGFR3 transcriptional regulation could help explain 
the over-expression observed in UC and BN patients. 
Several tools and algorithms already exist for scoring known transcription factor 
binding motifs in gene promoters. In most cases, however, a combination of dif-
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ferent methodologies is required to minimize false positives. For example, TFBSs 
found in evolutionary conserved regions (ECRs) identified by cross-species com-
parative analysis have an increased likelihood of playing a role in gene regulation. 
In addition to this, expression correlation may also be due to a regulatory relation-
ship. Finally, as transcription factors often work cooperatively, binding in close 
physical proximity, co-occurring motifs can indicate the presence of regulatory 
modules. The configuration of such modules can be, up to some extent, evolutio-
narily conserved, as regulatory elements driving shared temporal and/or spatial 
aspects of gene expression are most probably located on genomic elements that 
contain similar modules of certain TFBS [4]. Therefore, the finding of functional 
relationships or common expression patterns among genes that share the detected 
regulatory modules would further support the prediction. 
Material and Methods 
Regulatory region covering 2Kb 5’ from the transcription start site and the 5’UTR 
and first intron were obtained from Ensembl for human, chimpanzee, gorilla and 
mouse. Conserved TFBSs were detected in ECRs by ortholog multiple local 
alignment with MULAN [5].  
Expression data was obtained from GEO (http://www.ncbi.nlm.nih.gov/geo/) from 
three Bladder Cancer (Acc. GSE3167, GSE7476, GSE13507)  and one Benign 
Nevi  (Acc. GSE3189) RNA expression sets. Probes with low variability (Inter 
Quartil Range<0.5) were excluded and data was processed from CEL files, when 
available, with robust multiarray analysis (RMA). 
Sample selection was conducted to include normal tissue vs. diseased with high 
FGFR3 expression levels (case > mean(ctr) + sd(ctr)). In total, 87 controls and 100 
cases from 4 different experimental datasets were used.  
TFs with conserved binding sites in the FGFR3 promoter were analyzed for co-
expression with FGFR3 applying Pearson correlation to the expression data. Dif-
ferential expression (Rank Product) was also calculated for all TFs between nor-
mal tissue samples and disease samples with increased FGFR3 expression.  
Candidate TFBS modules were studied with SynoR [4] conducting human vs. 
mouse genome scans for conserved clusters of TFBS. 
Results 
TFBS detection in ECRs of the FGFR3 regulatory region returned 129 putative 
binding sites from 58 different transcription factors. Expression analysis was per-
formed for these TFs and consistent over-expression and positive correlation with 
FGFR3 was found for AP2α and TCF3 while EGR1 showed clear under-
expression and negative correlation  (Table 1, Fig. 1). 
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Fig. 1. Distribution of relevant TFBSs and conserved regions (ECRs) relative to FGFR3 gene 
features (line: intron; box: exon; grey: 5’UTR; black: CDS)  
Table 1. Results for Pearson correlation with FGFR3 expression. Arrows indicate differential 
expression of cases with high FGFR3 expression compared to controls. 
Dataset AP2-α AP2-γ TCF3 TFDP1 SP1 EGR2 EGR1 N 
BC-GSE3167  0.55 ↑  0.09  0.70 ↑  0.71 ↑ - - -0.57 ↓ 18 
BC-GSE7476  0.89 ↑↑  0.06 ↑  0.73 ↑  0.61 ↑ - -0.68 -0.80 ↓↓ 6 
BC-GSE13507  0.69 ↑↑  0.33  0.38 ↑↑ -0.23  0.4 ↑↑ -0.55 ↓↓ -0.56 ↓↓ 140 
BN-GSE3189  0.82 ↑↑  0.82 ↑↑  0.63 ↑  0.79 ↑  0.5 ↑ -0.55 ↓↓ -0.69 ↓↓ 23 
 
The TCF3 gene encodes the alternative spliced TFs, E12 and E47. The latter 
plays major roles in embryogenesis and its phosphorylation is regulated by a 
MAPK. TFDP1 shows overexpression and correlation with FGFR3 in three out of 
four experiments (Table 1). This TF is a dimerization partner for the E2F family 
of TFs, which play a key role in cell cycle regulation. It is noteworthy that FGFR3 
overexpression has been observed after adenoviral infection with E2F-1 [6,7]. 
Overlapping EGR and SP1 sites have been found in the first intron of FGFR3. 
EGR1 is known to interact with SP1 (MINT, Acc. 7384908) and is associated with 
negative regulation of transcription (GO:122). Moreover, repressor activity of 
Egr-1 has been reported, probably by preventing interactions between SP1 and the 
transcriptional machinery [8]. Interestingly, Egr-1 is upregulated by FGF1 [9], so 
an expression decrease should not be expected when MAPK pathway is active.  
These results suggest an activating role for AP2α and E47 and a possible re-
pression activity of EGR1. 
Two evolutionary conserved modules of the detected TFs have been identified 
with SynoR: (1) a promoter module (PM) consisting of clusters of  SP1, E2F1, 
EGR and E47 binding sites and (2) an intronic module (IM) with AP2, EGR and 
SP1 TFBSs. Instances of the PM have been found in ECRs of 634 genes and IM 
instances in ECRs of 799 genes. Only 10% of the IM instances were found within 
coding sequences while most were located in regions with possible regulatory 
function like promoters (35%) and introns (32%). Functional relationships and 
common expression patterns have also been found between FGFR3 and the genes 
with PM or IM detected in non-coding regions. 
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Conclusions 
Two different conserved TF modules have been identified in the promoter and 
first intron of FGFR3 gene. These modules contain activating AP2, E47, E2F and 
SP1 binding sites and motifs for EGR with possible repressor function. 
AP2α is the AP2 family member with best correlation with FGFR3 expression. 
Therefore, AP2α might have a stronger regulatory effect in UC and BN than 
AP2δ, whose FGFR3 activating function have already been reported in neuroblas-
toma cell lines [2]. 
A strong correlation with FGFR3 expression has been found for E47. This TF is 
functionally associated with the MAPK pathway and has been shown to induce 
FGFR3 expression in reporter assays [3]. It is, therefore, likely to play a role in the 
transcriptional regulation of FGFR3 expression. 
The inverse correlation observed between the expression levels of EGR1 and 
FGFR3 suggests that EGR1 may be repressing FGFR3. The detection of overlap-
ping SP1 and EGR1 sites (Fig. 1) are consistent with the repression mechanism 
proposed by Tan et al. [8] where EGR1 would interfere with the transcriptional 
activity of SP1 by binding to overlapping sites. 
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